Tag

Khiron is now shipping its branded EU-GMP certified medical cannabis to Germany, providing immediate access to the German market through its distribution partner, Nimbus Health GmbH. Khiron teams continue to educate physicians with plans to leverage clinical evidence from both...

Like several other companies in Colombia, Khiron (TSX.V: KHRNF) cultivates and processes cannabis at its agricultural facilities in Ibagué, Tolima. But Khiron takes the unique approach of launching and operating a chain of integrative medical clinics under its Zerenia brand,...

Khiron Life Sciences this week announced that it has received manufacturing quotas from the Colombian TQG that authorize the company to manufacture high-THC whole plant extract for both export and domestic purposes.

The UN body allocated 131,000 pounds of dried marijuana flower production to Colombia, 21.84% of the entire world total.

Khiron Life Sciences Corp. ( (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), has announced that its wholly-owned clinic network, the Latin American Institute of Neurology and the Nervous System (“ILANS”), has partnered with Colombian health insurance company...

"There has been a lot of progress," said Lagos. "In Chile, the fact that [legalizing] the personal consumption of medicinal cannabis is being discussed is a sign of progress."

The Canadian company with its main operations in Colombia sold more than 14.3 million common shares for $0.90 per share to raise the funding.

David Gordon, former managing partner in Canada for global public relations firm Cohn & Wolfe, will step into his role with PharmaCielo on October 1.

"This acquisition represents a significant milestone for the cannabis industry, being the first in which a major multinational agricultural corporation has taken a position in a joint venture of this nature,” said Avicanna.

Khiron CEO Alvaro Torres says adding Fox to the board of directors “significantly expands our scope of influence and relationships within the Latin American market.”